157 related articles for article (PubMed ID: 3258791)
1. Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB.
Orlandi R; Canevari S; Conde FP; Leoni F; Mezzanzanica D; Ripamonti M; Colnaghi MI
Cancer Immunol Immunother; 1988; 26(2):114-20. PubMed ID: 3258791
[TBL] [Abstract][Full Text] [Related]
2. The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells.
Conde FP; Orlandi R; Canevari S; Mezzanzanica D; Ripamonti M; Muñoz SM; Jorge P; Colnaghi MI
Eur J Biochem; 1989 Jan; 178(3):795-802. PubMed ID: 2783572
[TBL] [Abstract][Full Text] [Related]
3. Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.
Rathore D; Batra JK
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):815-22. PubMed ID: 9210405
[TBL] [Abstract][Full Text] [Related]
4. A gelonin-containing immunotoxin directed against human breast carcinoma.
Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR
Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665
[TBL] [Abstract][Full Text] [Related]
5. Generation of active immunotoxins containing recombinant restrictocin.
Rathore D; Batra JK
Biochem Biophys Res Commun; 1996 May; 222(1):58-63. PubMed ID: 8630074
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of ribonucleolytic toxin restrictocin-based chimeric toxins targeted to epidermal growth factor receptor.
Rathore D; Batra JK
FEBS Lett; 1997 May; 407(3):275-9. PubMed ID: 9175867
[TBL] [Abstract][Full Text] [Related]
7. Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
Dosio F; Arpicco S; Adobati E; Canevari S; Brusa P; De Santis R; Parente D; Pignanelli P; Negri DR; Colnaghi MI; Cattel L
Bioconjug Chem; 1998; 9(3):372-81. PubMed ID: 9576812
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen.
Chan MC; Murphy RM
Cancer Immunol Immunother; 1999 Feb; 47(6):321-9. PubMed ID: 10203062
[TBL] [Abstract][Full Text] [Related]
9. Heterologous expression of the cytotoxin restriction in Aspergillus nidulans and Aspergillus niger.
Brandhorst T; Yang R; Kenealy WR
Protein Expr Purif; 1994 Oct; 5(5):486-97. PubMed ID: 7827506
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.
Tonevitsky AG; Agapov II; Mechetner EB; Ershova GV; Toptygin AYu ; Sarma T; Shamshiev AT; Pfueller U
Biochem Mol Biol Int; 1993 Dec; 31(6):1059-69. PubMed ID: 8193589
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker.
Suzawa T; Nagamura S; Saito H; Ohta S; Hanai N; Kanazawa J; Okabe M; Yamasaki M
J Control Release; 2002 Feb; 79(1-3):229-42. PubMed ID: 11853934
[TBL] [Abstract][Full Text] [Related]
12. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
Rosenblum MG; Marks JW; Cheung LH
Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
[TBL] [Abstract][Full Text] [Related]
13. Role of individual cysteine residues and disulfide bonds in the structure and function of Aspergillus ribonucleolytic toxin restrictocin.
Nayak SK; Rathore D; Batra JK
Biochemistry; 1999 Aug; 38(31):10052-8. PubMed ID: 10433712
[TBL] [Abstract][Full Text] [Related]
14. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
Goyal A; Batra JK
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
[TBL] [Abstract][Full Text] [Related]
15. Regulation of restrictocin production in Aspergillus restrictus.
Yang R; Kenealy WR
J Gen Microbiol; 1992 Jul; 138(7):1421-7. PubMed ID: 1512574
[TBL] [Abstract][Full Text] [Related]
16. Construction and pathogenicity of Aspergillus fumigatus mutants that do not produce the ribotoxin restrictocin.
Smith JM; Davies JE; Holden DW
Mol Microbiol; 1993 Sep; 9(5):1071-7. PubMed ID: 7934913
[TBL] [Abstract][Full Text] [Related]
17. Isolation and nucleotide sequence of the Aspergillus restrictus gene coding for the ribonucleolytic toxin restrictocin and its expression in Aspergillus nidulans: the leader sequence protects producing strains from suicide.
Lamy B; Davies J
Nucleic Acids Res; 1991 Mar; 19(5):1001-6. PubMed ID: 2020539
[TBL] [Abstract][Full Text] [Related]
18. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates.
Candiani C; Franceschi A; Chignola R; Pasti M; Anselmi C; Benoni G; Tridente G; Colombatti M
Cancer Res; 1992 Feb; 52(3):623-30. PubMed ID: 1732050
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
Griffin TW; Pagnini PG; Houston LL
J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
[TBL] [Abstract][Full Text] [Related]
20. The ribosome-inactivating protein restrictocin deters insect feeding on Aspergillus restrictus.
Brandhorst T; Dowd PF; Kenealy WR
Microbiology (Reading); 1996 Jun; 142 ( Pt 6)():1551-1556. PubMed ID: 8704996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
